In order to most effectively treat cancer, it’s important that it is detected as early as possible before it begins to spread throughout your body. This panel has tumor markers that exist to help detect cancers of the liver, testicles, pancreas, gastrointestinal tract, and prostate.
Cancer Marker Tests are immunological methods, which are cancer markers that are produced as cancer develops, and can be detected before it reaches the certain size that enables other methods to detect it. Early medical intervention can be applied to improve the chance of recovery if an early detection system, such as an immunological method, is being used.
The Male Cancer Extended Panel takes an investigative approach into your health, further assessing potential areas where cancer may be present. Your test results in isolation won’t be sufficient for a cancer diagnosis, however, consulting with your physician will give you a better understanding of what your results mean and how you can use them to stay one step ahead of cancer.
Prostate Specific Antigen - is a protein produced primarily by cells in the prostate. It is used to screen men for prostate cancer and can also help determine the necessity for a biopsy of the prostate or to monitor the effectiveness of treatment for prostate cancer
CA 19.9 - helps differentiate between cancer of the pancreas and other conditions. Also can monitor response to pancreatic cancer treatment and aid in watching for recurrence
AFP (Alpha-Fetoprotein) - helps diagnose and monitor therapy for certain cancers of the liver, testicles, or ovaries. May be ordered, along with imaging studies, to try to detect liver cancer when it is in its earliest and most treatable stages.
HCG (Human Chronic Gonadotropin) - helps diagnose and monitor gestational trophoblastic disease or germ cell tumors. Since hCG is not normally present in men or non-pregnant women, it is useful as a tumor marker. If a tumor or cancer is producing hCG, then the hCG test can be used to help detect and monitor tumor activity
CEA - primarily used to monitor cancer treatment, including response to therapy and recurrence. Also used as an indicator of the amount of cancer or size of tumor present and to assist in determining prognosis (how the cancer is to progress). Helps determine if cancer has spread (metastasis)